Generate Biomedicines, Inc. (GENB) IV/HV History

Comparing implied volatility to historical (realized) volatility reveals whether options are priced rich or cheap relative to actual price movement. Persistent gaps can signal trading opportunities.

Generate Biomedicines, Inc. (GENB) operates in the Financial Services sector, specifically the Asset Management industry, with a market capitalization near $1.68B, listed on NASDAQ, employing roughly 312 people, carrying a beta of 0.00 to the broader market. Generate Biomedicines, Inc. Led by Michael T. Nally, public since 2026-02-27.

IV/HV history compares implied volatility to realized volatility over time. No recent options activity for GENB as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how implied vs realized volatility is reported and how to read the data →